共 110 条
[1]
Genovese G(2019)New insights into the pathogenesis of bullous pemphigoid: 2019 update Front. Immunol. 10 1506-599
[2]
Kridin K(2018)The growing incidence of bullous pemphigoid: overview and potential explanations Front. Med. 5 220-1491
[3]
Ludwig RJ(2011)Comorbidity profiles among patients with bullous pemphigoid: a nationwide population-based study Br. J. Dermatol. 165 593-311
[4]
Chen YJ(2018)Comorbidities and treatment strategies in bullous pemphigoid: an appraisal of the existing literature Front. Med. 5 238-99
[5]
Bech R(2017)Increased frequency of multiple sclerosis among patients with bullous pemphigoid: a population-based cohort study on comorbidities anchored around the diagnosis of bullous pemphigoid Br. J. Dermatol. 176 1486-33
[6]
Kibsgaard L(2015)A retrospective consecutive case-series study on the effect of systemic treatment, length of admission time, and co-morbidities in 98 bullous pemphigoid patients admitted to a tertiary centre Acta. Derm. Venereol. 95 307-208
[7]
Vestergaard C(2017)Hospitalization, inpatient burden and comorbidities associated with bullous pemphigoid in the USA Br. J. Dermatol. 176 87-193
[8]
Kibsgaard L(2017)BPAG1 in muscles: Structure and function in skeletal, cardiac and smooth muscle Semin. Cell. Dev. Biol. 69 26-54
[9]
Rasmussen M(2018)Management of inflammatory bowel disease in older persons: evolving paradigms Intest. Res. 16 194-2778
[10]
Lamberg A(2016)Inflammatory bowel disease and the risk of autoimmune diseases J. Crohn's. Colitis. 10 186-62